683 Capital Management, LLC Aadi Bioscience, Inc. Transaction History

683 Capital Management, LLC

  • $1.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.46 - $2.31 $175,200 - $277,200
-120,000 Reduced 60.0%
80,000 $116,000
Q4 2023

Feb 14, 2024
BUY
$1.97 - $5.41 $394,000 - $1.08 Million
200,000 New
200,000 $404,000
Q2 2022

Aug 15, 2022
SELL
$11.57 - $17.92 $208,549 - $323,008
-18,025 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$19.32 - $29.02 $348,243 - $523,085
18,025 New
18,025 $435,000

Others Institutions Holding AADI

# of Institutions
55
Shares Held
12.6M
Call Options Held
23.8K
Put Options Held
0
View Full List

About Aadi Bioscience, Inc.

AADI Quotes by TradingView
  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $48.3M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email